Clinical Nutrition Market Is Expected to Reach $51.12 Billion by 2028 | Danone Nutricia, Baxter International, Pfizer

March 18, 2025 12:04 AM AEDT | By EIN Presswire
 Clinical Nutrition Market Is Expected to Reach $51.12 Billion by 2028 | Danone Nutricia, Baxter International, Pfizer
Image source: EIN Presswire
PORTLAND, IA, UNITED STATES, March 17, 2025 /EINPresswire.com/ -- According to the report published by Allied Market Research, the global Clinical Nutrition Market was estimated at $32.49 billion in 2020 and is expected to hit $51.12 billion by 2028, registering a CAGR of 6.1% from 2021 to 2028. The report provides a detailed analysis of the top investment pockets, top winning strategies, drivers & opportunities, market size & estimations, competitive landscape, and evolving market trends.

Download Sample Report at: https://www.alliedmarketresearch.com/request-sample/861

Increase in incidences of chronic diseases and lifestyle associated disease and surge in geriatric population across the globe drive the growth of the global clinical nutrition market. On the other hand, lack of awareness for clinical nutrition and stringent regulations and poor reimbursement policies impede the growth to some extent. However, various growth opportunities in emerging economies are expected to be beneficial for the market growth.

Clinical nutrition refers to the nutrition of patients in the healthcare industry or clinical refers to the management of outpatients as well as inpatients in clinics and hospitals. It aims to maintain a healthy energy balance in patients, as well as providing require amounts of other nutrients such as protein, vitamins, minerals, etc. The advantages of clinical nutrition are, it is very effective in treating type 1 or type 2 diabetes and helps one to live better at any age. Clinical nutrition products are outwardly provided to patients who are unable to digest certain nutrients products. These products help in improving metabolisms, digestion, absorption, transportation, storage, and discharge of the human body.

Enquire Before Buying: https://www.alliedmarketresearch.com/purchase-enquiry/861

By end-user, the pediatric segment held the major share in 2020, accounting for more than two-fifths of the global market. The same segment would also cite the fastest CAGR of 6.9% by the end of 2028.

By geography, North America garnered the highest share in 2020, holding around one-third of the global clinical nutrition market. The market across Asia-Pacific, on the other hand, would showcase the fastest CAGR of 7.2% from 2021 to 2028. The other two provinces covered in the report include Europe, and LAMEA.

The key market players analyzed in the global clinical nutrition market report include B. Braun Melsungen AG, Abbott Laboratories, Hero Nutritionals Inc., Baxter International Inc., Fresenius SE & Co. KGaA, Perrigo Company Plc, Pfizer Inc., Lonza Ltd, Nestlé S.A., and Danone Nutricia. These market players have embraced several strategies including partnership, expansion, collaboration, joint ventures, and others to highlight their prowess in the industry.

Avenue Basic Plan | Library Access | 1 Year Subscription |

Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan.

Avenue Library Subscription | Request for 14 days free trial of before buying: https://www.alliedmarketresearch.com/avenue/trial/starter

Key Findings Of The Study:

By application, the gastrointestinal disorders and metabolic disorders segments collectively accounted for around 67.5% clinical nutrition market share in 2020, with the former constituting around 36.7% share of the global clinical nutrition market in 2020 to 2028.

By route of administration, the enteral segment is anticipated to grow at the CAGR of 7.30% during the analysis period.

By end user, the pediatric and geriatric segment held the largest share around 79.6% in 2020 and is anticipated to maintain its dominance throughout the forecast period.

By region, the Asia-Pacific market is anticipated to experience 7.20% CAGR during the forecast period.

About Allied Market Research:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Wilmington, Delaware. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

David Correa
Allied Market Research
+ 1800-792-5285
email us here
Visit us on social media:
Facebook
X
LinkedIn
YouTube

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.


AU_advertise

Advertise your brand on Kalkine Media

Sponsored Articles


Investing Ideas

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.